Neven P, Iles R K, Howes I, Sharma K, Shepherd J H, Edwards R, Collins W P, Chard T
Williamson Laboratory for Molecular Oncology, Joint Academic Department of Obstetrics, Gynaecology and Reproductive Physiology, St. Bartholomew's Hospital Medical College, West Smithfield, London, UK.
Clin Chem. 1993 Sep;39(9):1857-60.
We measured the day-to-day variations in concentrations of beta-core, luteinizing hormone (LH), and alpha-subunit in urine during the menstrual cycle. The alpha-subunit concentrations showed a pattern similar to that of the LH concentrations. beta-Core-like material was increased during and up to 3 to 4 days after the surge in urine LH. The urine LH concentration was associated with the presence of beta-core immunoreactivity during the urine LH peak. Chromatography showed that, at the peak LH concentration and at 2 days after the LH peak, beta-core immunoreactivity could be accounted for by the presence of a peptide of low molecular mass similar to the beta-core molecule of hCG, but probably originating from the degradation of LH. The prolonged excretion of gonadotropin metabolites in the midcycle must be considered when beta-core is being assessed as a tumor marker.
我们测量了月经周期中尿液中β-核心、促黄体生成素(LH)和α-亚基浓度的每日变化。α-亚基浓度呈现出与LH浓度相似的模式。在尿液LH激增期间及之后3至4天,β-核心样物质增加。在尿液LH峰值期间,尿液LH浓度与β-核心免疫反应性的存在相关。色谱分析表明,在LH浓度峰值时以及LH峰值后2天,β-核心免疫反应性可由一种低分子量肽的存在来解释,该肽类似于hCG的β-核心分子,但可能源自LH的降解。在将β-核心评估为肿瘤标志物时,必须考虑到中期促性腺激素代谢产物的排泄延长情况。